Kang Stem Biotech Co., Ltd.

Quick facts

Phase 3 pipeline

• FURESTEM-AD Inj. · Dermatology / Immunology
  FURESTEM-AD is an allogeneic adipose tissue-derived mesenchymal stem cell product that modulates immune responses and promotes tissue repair in atopic dermatitis.

Phase 2 pipeline

• FURESTEM-RA Inj.

Phase 1 pipeline

• FURESTEM-CD Inj.
• FURESTEM-OA Kit Inj.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Kang Stem Biotech Co., Ltd. portfolio CI brief
• Kang Stem Biotech Co., Ltd. pipeline updates RSS